In an era of rapid advancement in rehabilitation technology, and to better leverage the industrial synergy of the Beijing-Tianjin-Hebei region while driving innovation and progress in the broader health and medical field, Beijing Soft Robot Technology Co., Ltd. (SRT) and the R&D Center of Xiu Zheng Health Group officially announced the establishment of a strategic partnership on August 21. The two parties jointly inaugurated the “Joint Laboratory for Rehabilitation Device Technology and Application” (hereinafter referred to as the “Joint Laboratory”).
Inauguration | Joint Laboratory for Rehabilitation Device Technology and Application Officially Unveiled
The cooperation signing and plaque unveiling ceremony was held at SRT headquarters. Zhao Xin, Chairman of SRT, Bao Lei, CTO of SRT, together with a five-person delegation including Wu Zonghan, R&D Director of the Tianjin R&D Branch of Jilin Xiu Zheng Health Co., Ltd., and Li He, R&D Manager, attended the ceremony.
Cooperation Background
At present, we are in a critical period when the state is vigorously promoting the coordinated development of the Beijing-Tianjin-Hebei region. The year 2024 also marks the tenth anniversary of this initiative being elevated to a national strategy. Over the past decade, the Beijing-Tianjin-Hebei region has made significant progress in education, healthcare, industrial coordination, and technology, positioning itself as a pilot and demonstration zone for Chinese-style modernization. In the broader health and medical field, the coordinated development of healthcare among the three regions is an important part of this national strategy and a key pillar for high-quality development. Therefore, how to fully demonstrate the level of innovation synergy in the Beijing-Tianjin-Hebei region, strengthen industrial chain collaboration and industry-university-research interaction in the medical device sector, and promote complementary advantages and joint improvement between rehabilitation theory and engineering technology has become the critical basis for establishing the in-depth cooperation of the “Joint Laboratory.”
As an early-stage enterprise in China dedicated to soft robotics technology R&D, SRT possesses unique strengths in developing rehabilitation medical devices. By integrating clinical rehabilitation needs and rehabilitation theory, SRT applies soft robotics technology to the field of hand rehabilitation. Meanwhile, as a leader in the pharmaceutical industry, Xiu Zheng Health Group has strong pharmaceutical R&D capabilities, extensive market resources, a complete business chain, and comprehensive strength. The strong alliance between the two parties will bring a revolutionary transformation to the field of rehabilitation devices.
August 21 | Cooperation Signing Ceremony Held at SRT Headquarters
Positioning of the Joint Laboratory
The Joint Laboratory for Rehabilitation Device Technology and Application is established based on the national strategy for the coordinated development of the Beijing-Tianjin-Hebei region and the “Healthy China 2030” plan. It leverages the complementary strengths of both parties in technology R&D and collaborative production, integrating their R&D capabilities, engineering technology, market channels, and other resources. The laboratory aims to advance technological cooperation, academic exchanges, talent cultivation, industry standard setting, and the translation of R&D achievements into practical applications. It is dedicated to promoting the development, manufacturing, and dissemination of a series of advanced medical devices in the broader health and medical field, thereby supporting technological and industrial progress in China’s healthcare sector.
Appointment | Wu Zonghan (right) as Director of the Joint Laboratory for Rehabilitation Device Technology and Application
Appointment | Bao Lei (left) as Deputy Director of the Joint Laboratory for Rehabilitation Device Technology and Application
Development Prospects
Against the backdrop of strengthening collaborative innovation in the Beijing-Tianjin-Hebei region, continuously leveraging Beijing’s advantages in technological innovation and Tianjin’s strengths in advanced manufacturing R&D, and promoting the deep integration of the industrial chain and innovation chain, the Joint Laboratory established by SRT and Xiu Zheng Pharmaceutical (Tianjin) is of great significance for both parties to further deepen their cooperation in the broader health and medical field.
The Joint Laboratory serves as a vivid example of technology empowering healthcare and co‑creating a healthy future. In their speeches, both parties stated that the Joint Laboratory will fully integrate their respective advantageous resources to achieve technological complementarity and resource sharing, actively assume social responsibilities, and strive to continuously contribute to the health and medical field. At the same time, SRT looks forward to learning from Xiu Zheng Pharmaceutical Group’s advanced technologies and concepts during the cooperation, continuously expanding the depth and breadth of technological exploration, jointly addressing development opportunities in the new era, laying a solid foundation for the long‑term development of both parties, and jointly enhancing the service capabilities of the broader health industry.